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Background/Aims
Esophageal baseline impedance (BI) can be extracted from pH-impedance tracings as mean nocturnal baseline impedance (MNBI), and 
from high-resolution impedance manometry (HRIM), but it is unknown if values are similar between acquisition methods across HRIM 
manufacturers. We aim to assess correlations between MNBI and BI from HRIM (BI-HRIM) from 2 HRIM manufacturers in the setting 
of physiologic acid exposure time (AET).
Methods
HRIM and pH-impedance monitoring demonstrating physiologic AET (< 4%) off proton pump inhibitors were required. BI-HRIM was 
extracted as the average from 5 cm and 10 cm above the lower esophageal sphincter. Distal BI-HRIM (DBI-HRIM) was also extracted 
from the most distal channel (Medtronic studies). MNBI was extracted from 6 channels. Concordance between BI-HRIM across 
manufacturers with MNBI was analyzed.
Results
Thirty-six patients met the inclusion criteria (59.6 ± 1.7 years; 22% female; body mass index 30.5 ± 0.7; AET 1.6 ± 0.2%). Although 
MNBI was similar at all channels (P ≥ 0.18), Diversatek BI-HRIM was lower than Medtronic BI-HRIM (P = 0.003). Overall, BI-HRIM 
correlated with MNBI at corresponding recording sites, 7 cm and 9 cm (P < 0.05), but not at other sites (P ≥ 0.19). Pearson’s 
correlations > 0.5 were seen at MNBI at 7 cm for both systems, and at 9 cm for Medtronic. DBI-HRIM correlated with MNBI at 3 cm 
and 5 cm (P < 0.03), but not at other locations (P > 0.1). 
Conclusions
While numeric differences exist between manufacturers, BI-HRIM correlates with MNBI from corresponding channels in patients with 
physiologic AET. Comparison with AET elevation is needed to determine correlations between pathologic MNBI with BI-HRIM across 
manufacturers. The optimal HRIM channels from which BI values should be extracted also warrants further study.
(J Neurogastroenterol Motil 2020;26:455-462)
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Introduction  
Ambulatory reflux monitoring is often utilized when symptoms 
suspicious for gastroesophageal reflux disease (GERD) persist de-
spite antisecretory therapy.1,2 Esophageal acid exposure time (AET) 
and reflux-symptom association (RSA) from ambulatory reflux 
monitoring can phenotype GERD and guide management.3-5 
While AET from pH monitoring remains the most consistent 
predictor of symptom outcome, combination with impedance moni-
toring increases RSA yield and enhances confidence in a reflux 
mechanism for symptoms.4,6 However, catheter-based ambulatory 
reflux monitoring provides only a cross-sectional assessment of 
reflux burden and may not capture day-to-day variation in reflux 
burden.7 
In contrast, esophageal baseline impedance (BI) is a novel 
marker for esophageal mucosal integrity, with lower values in ero-
sive and non-erosive GERD compared to functional heartburn and 
healthy controls.8,9 Extracted from the nocturnal phase of ambula-
tory pH-impedance tracings, mean nocturnal baseline impedance 
(MNBI) can segregate reflux-related esophageal syndromes from 
controls,10-12 and predicts symptom improvement from antireflux 
therapy as a co-variate of distal AET.13,14 However, acquiring BI in 
this fashion still requires cumbersome ambulatory catheter-based 
monitoring and manual analysis of tracings. 
High-resolution impedance manometry (HRIM), utilized to 
identify the lower esophageal sphincter (LES) for appropriate po-
sitioning of pH-impedance catheters, also incorporates impedance 
sensors to track esophageal bolus during pressure topography.15 BI 
acquired during the landmark phase of HRIM (BI-HRIM) per-
formed with Medtronic HRIM equipment has been demonstrated 
to correlate with MNBI and reliably segregate patients with mod-
erately pathologic AET from controls.16 
Despite growing evidence supporting the value of BI from 
both pH-impedance monitoring and HRIM in identifying reflux-
related esophageal syndromes, there is a paucity of similar data 
in patients with physiologic AET and functional esophageal syn-
dromes. Evaluation of BI-HRIM has only been conducted using 
HRIM catheters from a single manufacturer (Medtronic, Min-
neapolis, MN, USA). In this study, we investigated BI-HRIM 
and MNBI values among patients with physiologic AET, across 2 
HRIM device manufacturers to assess BI relationships with esoph-
ageal symptoms, and to determine if BI values are similar between 
HRIM devices in functional esophageal syndromes.
Materials and Methods  
Patients
Adults with persistent esophageal symptoms who underwent 
esophageal HRIM using 1 of 2 device manufacturers (Diversatek, 
Highlands Ranch, CO, USA; and Medtronic, Minneapolis, MN, 
USA) and combined pH-impedance monitoring (Diversatek) at 
the performing institution over a 2-year period were eligible for 
inclusion into this retrospective observational cohort study. Exclu-
sion criteria consisted of studies performed on antisecretory therapy, 
distal esophageal AET > 4%, achalasia, previous foregut surgery, 
inadequate studies (poor data quality precluding analysis), or in-
complete studies (< 14 hours of recording time); patients with 
esophageal body motor disorders without outflow obstruction were 
not excluded. This study protocol was approved by the Institutional 
Review Board at the performing institution (IRB No. 02083); a 
waiver of informed consent was granted by the Institutional Review 
Board.
High-resolution Impedance Manometry Baseline 
Impedance
HRIM from 1 of 2 manufacturers (Diversatek and Medtron-
ic) was used to localize the LES, identify motility disorders per Chi-
cago classification version 3.0,17 and determine BI from esophageal 
manometry (BI-HRIM). BI-HRIM was extracted from HRIM 
studies as the average of impedance values from 5 cm and 10 cm 
above the LES during quiet rest (“landmark phase”) prior to initia-
tion of water swallows.18 Distal BI-HRIM (DBI-HRIM) was also 
extracted from the distal-most esophageal impedance channel from 
Medtronic HRIM studies. 
pH-impedance Monitoring
Patients were instructed to stop their proton pump inhibitor 
(PPI) medications for 7 days prior to the study, and any hista-
mine-2 receptor antagonists, prokinetic medications, and antacids 
3 days prior to the study. After an overnight fast, an experienced 
nurse positioned the pH-impedance catheter (Diversatek) such that 
the esophageal pH sensor was 5 cm proximal to manometrically-lo-
calized LES. Throughout the monitoring interval, patients logged 
their meals, position (supine vs upright), and symptom events by 
pressing appropriate buttons on the data recorder. Data uploaded 
from pH-impedance studies were analyzed with dedicated software 
(Bioview Analysis; Diversatek), with calculation of AET, reflux 
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events, symptom events, and RSA parameters. AET was calculated 
as the percentage of time the pH was below 4 at the distal esopha-
geal pH sensor. AET < 4% was considered physiologic,19 and was 
an entry criterion for this study.
Symptom events were considered associated with reflux epi-
sodes if they occurred within 2 minutes of a reflux episode. Symp-
tom index was calculated as the ratio of symptom events associated 
with reflux episodes to total symptom events and considered posi-
tive if > 50%.20 Symptom association probability was calculated 
using the Ghillebert probability estimate,21 and designated positive 
if > 95%, corresponding to P < 0.05. 
pH-impedance tracings were interrogated by one of the au-
thors (A.H.) in a blinded fashion to calculate MNBI values. BI 
values were extracted at each impedance channel (3, 5, 7, 9, 15, and 
17 cm above the LES) across stable nocturnal 10-minute periods 
(at or around 1 AM, 2 AM, and 3 AM) to avoid reflux events or 
swallows.22 The values from the 3 time periods for each channel 
were averaged to yield the MNBI for each channel. Distal MNBI 
was calculated as the average of MNBI values from the channels 
located at 3, 5, 7, and 9 cm above the LES.13
Symptom Assessment
Prior to esophageal function testing at the performing institu-
tion, all patients completed symptom surveys to rate their dominant 
and secondary symptom frequency and severity on 5-point Likert 
scales, as well as esophageal global symptom severity (GSS) on 100-
mm visual analog scales, as previously described.4,5,23,24 Patients 
rate symptom frequency from 0 (no symptoms) to 4 (multiple daily 
episodes), and symptom severity from 0 (no symptoms) to 4 (very 
severe symptoms). Dominant symptom intensity (DSI) is then cal-
culated as the product of symptom frequency and symptom severity 
(for a total score from 0 to 16). The DSI and GSS represented 
symptom burden metrics for this study. Dominant symptoms were 
also stratified into perceptive (heartburn and chest pain) and non-
perceptive symptom groups.
Statistical Methods
Data are reported here as mean ± standard error of the mean, 
unless otherwise indicated. Categorical data were compared us-
ing the χ-squared test, and continuous data were compared using 
ANOVA or the 2-tailed Student’s t test, as appropriate. Correlations 









Age (yr) 59.6 ± 1.7 62.0 ± 2.2 58.1 ± 2.4 0.259
Gender (female) 8 (22%) 3 (21%) 5 (23%) 0.927
BMI 30.5 ± 0.7 29.9 ± 1.1 30.9 ± 0.9 0.473
Perceptive dominant symptom 27 (75%) 11 (79%) 16 (73%) 0.693
GSS 69.0 ± 4.5 62.9 ± 6.5 72.9 ± 6.0 0.279
DSI 10.4 ± 1.0 8.7 ± 1.7 11.4 ± 1.2 0.180
Normal esophageal body motility on HRM 25 (69%) 10 (71%) 15 (68%) 0.837
Total AET (%) 1.6 ± 0.2 1.2 ± 0.3 1.8 ± 0.3 0.247
BI-HRIM 1564 ± 140 1062 ± 124 1884 ± 186 0.003
MNBI-17 2184 ± 150 2387 ± 260 2055 ± 180 0.285
MNBI-15 2083 ± 149 2151 ± 230 2039 ± 199 0.719
MNBI-9 1553 ± 121 1703 ± 168 1458 ± 167 0.332
MNBI-7 1589 ± 148 1699 ± 226 1519 ± 198 0.561
MNBI-5 1474 ± 152 1713 ± 269 1322 ± 177 0.214
MNBI-3 1376 ± 139 1614 ± 274 1225 ± 142 0.175
Distal MNBIb 1498 ± 124 1683 ± 204 1381 ± 154 0.241
aComparison between Diversatek and Medtronic high-resolution impedance manometry (HRIM) systems (performed with independent-samples 
t tests or Chi-square, as appropriate).
bDistal mean nocturnal baseline impedance (MNBI) represents the averaged MNBI values for 3,5,7, and 9 cm above the lower esophageal sphinc-
ter (LES).
BMI, body mass index; GSS, global symptom severity; DSI, dominant symptom intensity; HRM, high-resolution manometry; AET, acid expo-
sure time; BI-HRIM, baseline impedance from HRIM. 
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between continuous variables (BI-HRIM, MNBI, and symptom 
burden) were quantified using Pearson’s correlation coefficient. In 
all cases, P < 0.05 was required for statistical significance. Statisti-




Inclusion criteria were met by 36 patients (age 59.6 ± 1.7 years, 
22% female, body mass index 30.5 ± 0.7), with a mean total AET 
of 1.6 ± 0.2% (Table 1). Dominant perceptive symptoms were 
reported by 75% of the cohort, and symptom burden was modestly 
high (GSS 69.0 ± 4.5, DSI 10.4 ± 1.0). Esophageal body motor 
function was normal in 25 patients (69%); of the remainder, 5 had 
ineffective esophageal motility, 4 had jackhammer esophagus, and 1 
each had absent contractility and diffuse esophageal spasm. HRIM 
was performed using Diversatek catheters in 14 (39%), and the 
remainder using Medtronic catheters. Demographics (age, gender, 
and body mass index), proportions with dominant perceptive symp-
toms, symptom burden metrics, proportions with normal esopha-
geal body motor function on HRM, and total AET were similar 
between HRIM manufacturer cohorts (P ≥ 0.180; Table 1). 
Mean Nocturnal Baseline Impedance and Baseline 
Impedance From High-resolution Impedance 
Manometry Values
Those with abnormal esophageal body motor function on 
HRM had similar BI-HRIM and MNBI values to those with 
normal body motor function (P > 0.369). Individual MNBI val-
ues at each impedance site as well as composite distal MNBI were 
similar between the 2 HRIM manufacturer cohorts (P ≥ 0.175; 
Table 1). In contrast, BI-HRIM acquired from Diversatek cath-
Table 2. Pearson Correlations With Baseline Impedance From High-resolution Impedance Manometry
MNBI, cm above the LES Total cohort (N = 36) Diversatek (n = 14) Medtronic (n = 22)
MNBI-17 –0.10 (P = 0.564) –0.04 (P = 0.885) –0.002 (P = 0.993)
MNBI-15 0.08 (P = 0.663) –0.07 (P = 0.806) 0.18 (P = 0.413)
MNBI-9 0.33 (P = 0.047) 0.22 (P = 0.451) 0.56 (P = 0.007)
MNBI-7 0.40 (P = 0.015) 0.51 (P = 0.064) 0.54 (P = 0.010)
MNBI-5 0.22 (P = 0.190) 0.36 (P = 0.202) 0.43 (P = 0.047)
MNBI-3 0.17 (P = 0.314) 0.26 (P = 0.379) 0.44 (P = 0.040)
Distal MNBIa 0.32 (P = 0.058) 0.39 (P = 0.167) 0.55 (P = 0.008)


























*pH sensor at 5 cm
Figure. Pearson correlations and corre-
sponding P-values for baseline imped-
ance from high-resolution impedance 
manometry (HRIM) by HRIM system 
(Medtronic or Diversatek) with mean 
nocturnal baseline impedance (MNBI) 
calculated at each Diversatek pH-
impedance channel.
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eters was significantly lower than that from Medtronic catheters 
(1062 ± 124 Ω vs 1884 ± 186 Ω, P = 0.003), despite similar 
symptom burden and AET in the 2 cohorts. 
Correlations Between Mean Nocturnal Baseline 
Impedance (MNBI) and Baseline Impedance From 
High-resolution Impedance Manometry (BI-HRIM)
Across the total cohort, there were statistically significant cor-
relations between BI-HRIM and MNBI at comparable chan-
nels––7 cm (r = 0.40, P = 0.015) and 9 cm (r = 0.33, P = 0.047) 
proximal to the LES––but not at other sites (P ≥ 0.19; Table 2 and 
Figure). Diversatek BI-HRIM numerically trended with MNBI 
at 7 cm (r = 0.51, P = 0.064), but not at the other MNBI sites (P 
≥ 0.202). Medtronic BI-HRIM correlated with MNBI at 3, 5, 
7, and 9 cm above the LES (r ≥ 0.43 and P ≤ 0.047 for all sites), 
but not at the proximal esophageal channels located at 15 cm and 
17 cm above the LES (P ≥ 0.413). 
DBI-HRIM from Medtronic catheters was also calculated 
from the most distal esophageal impedance sensor (1471 ± 172 
Ω). There were significant correlations between DBI-HRIM and 
the closest corresponding MNBI values at 3 cm (r = 0.58, P = 
0.005) and 5 cm (r = 0.48, P = 0.024; Table 3). However, these 
correlations incrementally decreased as MNBI was acquired from 
progressively proximal channels.
Correlations Between Baseline Impedance and 
Symptoms
Patients presenting with dominant perceptive symptoms had no 
significant differences in distal composite MNBI values, compared to 
those with dominant non-perceptive symptoms (perceptive: 1481 ± 
125 Ω, non-perceptive: 1549 ± 341 Ω; P = 0.816). Further, there 
were no differences in BI-HRIM values based on dominant per-
ceptive versus non-perceptive symptoms (Diversatek: 992 ± 90 Ω 
vs 1315 ± 530 Ω; P = 0.606; Medtronic: 1886 ± 217 Ω vs 1877 
± 395 Ω; P = 0.983). Although GSS and DSI correlated with 
each other (r = 0.65, P < 0.001), neither symptom burden metric 
correlated with distal composite MNBI (r < 0.05, P > 0.785), 
Medtronic BI-HRIM (r < 0.38, P > 0.081), or Diversatek BI-
HRIM (r < 0.40, P > 0.158).
Discussion  
In this study, we demonstrate that BI acquired from HRIM 
studies correlates with corresponding MNBI acquired from 24-
hour pH-impedance tracings in patients with physiologic AET 
tested off antisecretory therapy, with numerical differences noted 
between HRIM manufacturers. Although they shared similar 
MNBI values across all channels, BI-HRIM acquired from Di-
versatek catheters was significantly lower than that from Medtronic 
catheters. Further, BI-HRIM from Medtronic catheters correlated 
with MNBI across more measurement sites in the distal esophagus, 
with stronger Pearson correlation values, compared to Diversatek 
catheters. There were no apparent differences in MNBI or BI-
HRIM in patients presenting with dominant perceptive versus 
non-perceptive symptoms. Finally, no significant associations were 
noted between symptom burden metrics and BI values, regardless 
of method of acquisition or manufacturer.
Ambulatory pH-impedance monitoring, which combines 
esophageal pH monitoring with impedance sensors to define reflux 
events regardless of acidity, aids in the diagnosis and phenotyping 
of GERD.19,25,26 Recently, interest in impedance monitoring has 
focused on assessing esophageal mucosal integrity using baseline or 
mucosal impedance analysis.12 Specifically, esophageal acid exposure 
in both animals and humans induces changes in the mucosal integ-
rity of the esophagus, as seen histologically by increased numbers of 
dilated intracellular spaces, which corresponds with lower mucosal 
impedance values.8,9,27,28 BI values acquired from pH-impedance 
tracings (MNBI) have been described to negatively correlate with 
AET,9 predict symptomatic response with antireflux therapy,13 and 
Table 3. Pearson Correlations With Medtronic Distal Baseline Im-
pedance From High-resolution Impedance Manometry
MNBI, cm above the LES
Medtronic DBI-HRIMa
(n = 22)
MNBI-17 0.03 (P = 0.883)
MNBI-15 0.16 (P = 0.475)
MNBI-9 0.24 (P = 0.288)
MNBI-7 0.34 (P = 0.123)
MNBI-5 0.48 (P = 0.024)
MNBI-3 0.58 (P = 0.005)
Distal MNBIb 0.44 (P = 0.038)
aDistal baseline impedance from high-resolution impedance manom-
etry (DBI-HRIM) represents the baseline impedance from high-
resolution impedance manometry (BI-HRIM) obtained from the 
most distal esophageal impedance sensor using the Medtronic HRIM 
catheter.
bDistal mean nocturnal baseline impedance (MNBI) represents the 
averaged MNBI values for 3,5,7, and 9 cm above the lower esopha-
geal sphincter (LES).
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improve with the healing of esophagitis.13,29,30 MNBI has also been 
shown to distinguish non-erosive reflux disease (NERD) and reflux 
hypersensitivity from functional heartburn and healthy controls.10-12 
Compared to PPI-refractory NERD, PPI-responsive NERD is 
associated with lower MNBI.11,22 Even when AET is borderline or 
inconclusive, MNBI values correlate with symptomatic outcome 
with antireflux therapy.14 
Since HRIM catheters incorporate technology to measure 
esophageal impedance,15 BI-HRIM has potential to provide BI 
data without subjecting patients to ambulatory transnasal catheter-
based monitoring. We demonstrate that there are differences 
between BI recorded from the 2 manufacturers studied, and 
thresholds defined for one manufacturer may not apply to the other. 
Recent work from the Mayo group demonstrated that BI acquired 
from Medtronic HRIM studies correlated with MNBI (r = 0.59), 
and segregated patients with pathologic AET ≥ 5% from controls 
(AET ≤ 3%), with a threshold of 1582 Ω having a sensitivity of 
86.2% and specificity of 88.5% for GERD.16 While this proposed 
cutoff for BI-HRIM applies for Medtronic HRIM catheters, this 
may not be applicable for Diversatek HRIM catheters. 
The HRIM catheters differ in sensor morphology between 
these manufacturers––the Diversatek pressure sensors protrude 
from the catheter, while the Medtronic pressure sensors are more 
embedded along the catheter. Prior work has demonstrated vari-
ability in HRM software metrics (including integrated relaxation 
pressures) between solid-state manometry systems,31-35 and the Chi-
cago classification therefore acknowledges differences in threshold 
values for HRM metrics based on manometry systems (particularly 
for integrated relaxation pressures).17 Although these differences in 
solid-state manometry pressure sensors and metrics are established, 
similar investigations into potential differences in impedance sens-
ing between manometry systems have not been performed, to our 
knowledge.
Moreover, correlations between MNBI and BI-HRIM dif-
fered between Medtronic and Diversatek catheters. However, the 
optimal HRIM channels from which to extract BI values needs 
further investigation. Further, impedance values can be influenced 
by the presence of fluid in the esophageal lumen, and the absence 
of liquid content within the esophageal lumen cannot be completely 
excluded during a 10-15 minutes HRIM study, especially if there 
is concurrent esophageal hypomotility.36
Limitations in our study design temper our conclusions. This 
was a retrospective cohort study; patients were not randomized to 
undergo HRIM with a particular catheter manufacturer (or both, 
to serve as internal controls). Optimally, sequential studies with 
HRIM catheters from both manufacturers would have provided 
better comparison. Further, the strict parameters for study inclusion 
resulted in relatively small cohort sizes that could have resulted in 
insufficient power to detect potential differences. This study was 
performed at a tertiary care center among a population of veterans, 
with a skewed population of more male and older patients than most 
published esophageal motility cohorts, and thus generalizability to 
community gastroenterology practices may be limited. However, 
we believe that better understanding esophageal symptoms and 
disorders in this sometimes-overlooked population is an important 
consideration. Finally, treatment approaches and symptom outcome 
data were unavailable for the cohort.
In summary, we report that BI-HRIM correlates with MNBI 
extracted from corresponding impedance channels in patients with 
physiologic esophageal acid burden on testing off antisecretory 
therapy. Our study is unique in assessment of BI-HRIM between 
2 different HRIM manufacturers, demonstrating numeric differ-
ences in BI-HRIM based on HRIM manufacturer. Further work 
is needed to determine the optimal HRIM channels from which 
to extract BI for maximal clinical value, and comparison in patients 
with corresponding AET elevation is warranted to better under-
stand the associations between MNBI, BI-HRIM, and esophageal 
acid exposure.
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